Alvotech (ALVO) Finished Goods (2022 - 2023)

Alvotech's (ALVO) quarterly Finished Goods came in at $1.5 million in Q2 2023, down 28.62% on a QoQ basis from $2.1 million in Q4 2022.

Alvotech (ALVO) Finished Goods (2022 - 2023) Analysis & Trends

Alvotech (ALVO) has 2 years of Finished Goods data on file, last reported at $1.5 million in Q2 2023.

Quarterly Finished Goods changed N/A year-over-year to $1.5 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $1.5 million (changed N/A YoY) and the FY2022 annual result came in at $2.1 million, changed N/A from the prior year.
Finished Goods fell to $1.5 million in Q2 2023, from $2.1 million in the prior quarter.
In the past five years, Finished Goods ranged from a high of $2.1 million in Q4 2022 to a low of $1.5 million in Q2 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-
2	Teva Pharmaceutical Industries	42.85 Bn	39.19 Bn	2.15 Bn
3	Zoetis	31.40 Bn	29.73 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn
5	United Therapeutics	22.16 Bn	19.49 Bn	683.80 Mn
6	Viatris	18.71 Bn	17.83 Bn	1.46 Bn
7	Neurocrine Biosciences	15.42 Bn	15.03 Bn	935.80 Mn
8	Elanco Animal Health	11.70 Bn	11.17 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.09 Bn	9.93 Bn	-
10	Alvotech	1.25 Bn	1.25 Bn	5.09 Mn

Download Data

Date	Value
Jun 30, 2023	1.51 Mn
Dec 31, 2022	2.12 Mn